Cargando…

Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?

Detalles Bibliográficos
Autor principal:	Antoniazzi, Luiza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2018
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263466/ https://www.ncbi.nlm.nih.gov/pubmed/30517377 http://dx.doi.org/10.5935/abc.20180235

Ejemplares similares

The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma
por: Hussain, Azhar, et al.
Publicado: (2023)

Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
por: Radaelli, Graciane, et al.
Publicado: (2018)

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

The Lack of Nutritional Counseling during Hospitalization
por: Antoniazzi, Luiza
Publicado: (2019)

Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues
por: Langslet, Gisle, et al.
Publicado: (2021)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
por: Hamilton-Craig, Ian, et al.
Publicado: (2010)

The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia
por: Pang, Jing, et al.
Publicado: (2020)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
por: Braamskamp, Marjet J. A. M., et al.
Publicado: (2015)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

Statins: benefits and risks revisited
por: Balaz, Miroslav, et al.
Publicado: (2019)

What Arteries are Affected in Familial Hypercholesterolemia?
por: Harada-Shiba, Mariko
Publicado: (2019)

When Do Paediatric Patients with Familial Hypercholesterolemia Need Statin Therapy?(*)
por: Hennig, Matylda, et al.
Publicado: (2017)

Can Achilles Tendon Assessment of Adult Familial Hypercholesterolemia be Reflected as a Risk Factor for Arteriosclerosis?
por: Hamaguchi, Hirotoshi
Publicado: (2022)

Familial hypercholesterolemia supravalvular aortic stenosis and extensive atherosclerosis
por: Prajapati, Rajpal, et al.
Publicado: (2018)

Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia
por: Hopkins, Paul N.
Publicado: (2017)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

Can We Clarify the Causative Gene/Variants Underlying Familial Hypercholesterolemia and Improve Genetic Diagnosis Rate?
por: Hori, Mika
Publicado: (2022)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
por: Marco-Benedí, Victoria, et al.
Publicado: (2021)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
por: Chan, Melody Lok-Yi, et al.
Publicado: (2022)

Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
por: Bays, Harold E., et al.
Publicado: (2021)

Impact of Familial Hypercholesterolemia Diagnosis in Real-World Data
por: Harada-Shiba, Mariko
Publicado: (2023)

Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia
por: Motkowski, Radosław, et al.
Publicado: (2020)

Statins: the high risks of discontinuation and large benefits of continuation
por: Hennekens, Charle H., et al.
Publicado: (2011)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Innate and Acquired Cellular Immunity in Children with Familial Hypercholesterolemia Treated with Simvastatin
por: Motkowski, Radosław, et al.
Publicado: (2022)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The Roles of Genetic Analysis in the Diagnosis of Pediatric Patients with Familial Hypercholesterolemia
por: Harada-Shiba, Mariko
Publicado: (2022)

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018)

New algorithms for treating homozygous familial hypercholesterolemia
por: Tromp, Tycho R., et al.
Publicado: (2022)

Statin withdrawal and treating COVID‐19 patients
por: Fedson, David S.
Publicado: (2021)

Benefit of Early Statin Therapy in Acute Myocardial Infarction in Korea
por: Jeong, Han Saem, et al.
Publicado: (2019)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
por: NODARI, SAVINA, et al.
Publicado: (2007)

Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners
por: Khoury, Michael
Publicado: (2023)

May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
por: Scicali, Roberto, et al.
Publicado: (2020)

Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia
por: Ruiz-Pesini, Eduardo, et al.
Publicado: (2022)

Features of Serum Fatty Acids at Acute Ischemic Stroke Onset in Statin-Treated Patients with Hypercholesterolemia
por: Mori, Takahisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bpr870bq9sgkpe3hk7e0ijc7b9